Literature DB >> 12381843

Characterization of the LDL-A module mutants of Tva, the subgroup A Rous sarcoma virus receptor, and the implications in protein folding.

Qing-Yin Wang1, Balaji Manicassamy, Xuemei Yu, Klavs Dolmer, Peter G W Gettins, Lijun Rong.   

Abstract

Tva is the cellular receptor for subgroup A Rous sarcoma virus (RSV-A), and the viral receptor function is solely determined by a 40-residue motif called the LDL-A module of Tva. In this report, an integral approach of molecular, biochemical, and biophysical techniques was used to examine the role of a well-conserved tryptophan of the LDL-A module of Tva in protein folding and ligand binding. We show that substitution of tryptophan by glycine adversely affected the correct folding of the LDL-A module of Tva, with only a portion giving a calcium-binding conformation. Furthermore, we show that the misfolded LDL-A conformations of Tva could not efficiently bind to its ligand. These results indicate that this conserved tryptophan in the LDL-A module of Tva plays an important role in correct protein folding and ligand recognition. Furthermore, these results suggest that the familial hypercholesterolemia (FH) French Canadian-4 mutation is likely caused by protein misfolding of low-density lipoprotein receptor, thus explaining the defect for this class of FH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381843      PMCID: PMC2373729          DOI: 10.1110/ps.0219802

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  Solution structure of the viral receptor domain of Tva and its implications in viral entry.

Authors:  Qing-Yin Wang; Wen Huang; Klavs Dolmer; Peter G W Gettins; Lijun Rong
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  The solution structure of the viral binding domain of Tva, the cellular receptor for subgroup A avian leukosis and sarcoma virus.

Authors:  M Tonelli; R J Peters; T L James; D A Agard
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

3.  NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin.

Authors:  K Dolmer; W Huang; P G Gettins
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

4.  Solution structure of the sixth LDL-A module of the LDL receptor.

Authors:  C L North; S C Blacklow
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

5.  Role of calcium in protein folding and function of Tva, the receptor of subgroup A avian sarcoma and leukosis virus.

Authors:  Q Y Wang; K Dolmer; W Huang; P G Gettins; L Rong
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 6.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

7.  Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor.

Authors:  M Simonovic; K Dolmer; W Huang; D K Strickland; K Volz; P G Gettins
Journal:  Biochemistry       Date:  2001-12-18       Impact factor: 3.162

8.  Evidence that familial hypercholesterolemia mutations of the LDL receptor cause limited local misfolding in an LDL-A module pair.

Authors:  C L North; S C Blacklow
Journal:  Biochemistry       Date:  2000-10-31       Impact factor: 3.162

9.  Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins.

Authors:  D W Russell; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

10.  Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.

Authors:  V Esser; L E Limbird; M S Brown; J L Goldstein; D W Russell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

View more
  6 in total

1.  Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding.

Authors:  Xuemei Yu; Qing-Yin Wang; Ying Guo; Klavs Dolmer; John A T Young; Peter G W Gettins; Lijun Rong
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 2.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

3.  Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses.

Authors:  Tia Rai; Michael Caffrey; Lijun Rong
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.

Authors:  Daniel Elleder; Deborah C Melder; Katerina Trejbalova; Jan Svoboda; Mark J Federspiel
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.

Authors:  P Michael Conn; Emery Smith; Timothy Spicer; Peter Chase; Louis Scampavia; Jo Ann Janovick
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 6.  Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.

Authors:  P Michael Conn; David C Smithson; Peter S Hodder; M David Stewart; Richard R Behringer; Emery Smith; Alfredo Ulloa-Aguirre; Jo Ann Janovick
Journal:  Pharmacol Res       Date:  2013-12-25       Impact factor: 7.658

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.